Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

By Yokota Toshifumi   Pistilli Emidio   Duddy William   Nagaraju Kanneboyina  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 831-842

Informa Healthcare

Access to resources Recommend Favorite

Stem cell therapy for muscular dystrophy

By Sohn Regina Lee   Gussoni Emanuela  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-9

Informa Healthcare

Access to resources Recommend Favorite

Early Decrease of IIx Myosin Heavy Chain Transcripts in Duchenne Muscular Dystrophy

By Pedemonte M.   Sandri C.   Schiaffino S.   Minetti C.  

Biochemical and Biophysical Research Communications, Vol. 255, Iss. 2, 1999-02 ,pp. : 466-469

Elsevier

Access to resources Recommend Favorite

Increased Number of Caveolae and Caveolin-3 Overexpression in Duchenne Muscular Dystrophy

By Repetto S.   Bado M.   Broda P.   Lucania G.   Masetti E.   Sotgia F.   Carbone I.   Pavan A.   Bonilla E.   Cordone G.   Lisanti M.P.   Minetti C.  

Biochemical and Biophysical Research Communications, Vol. 261, Iss. 3, 1999-08 ,pp. : 547-550

Elsevier

Access to resources Recommend Favorite

Editorial (Thematic Issue: “An Overview on Proteins of Biomedical Importance in Targeted Therapy of Cancer, Duchenne Muscular Dystrophy and Protein Misfolding Associated Neuropathy: Structure Function Relationship, Mechanism of Action, Role of Small Molecule Antagonist and Future Perspective”)

By  

Current Chemical Biology, Vol. 8, Iss. 3, 2014-12 ,pp. : 115-116

Bentham Science Publishers

Access to resources Recommend Favorite